Imec and Imec spin-off miDiagnostics have signed a non-exclusive licensing agreement for Imec’s patented technology whereby aerosols and droplets from exhaled breath are captured for screening for viral RNA through miDiagnostics ultrafast PCR technology. The agreement enables miDiagnostics to kickstart the commercialization of a COVID-19 breathalyzer (as opposed to classical COVID-19 testing methods based on ...

This story continues at Imec licenses Covid detection technology

Or just read more coverage at Electronics Weekly